Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.740
-0.070 (-2.49%)
At close: Feb 27, 2026, 4:00 PM EST
2.720
-0.020 (-0.74%)
After-hours: Feb 27, 2026, 7:39 PM EST
Absci Market Cap
Absci has a market cap or net worth of $412.02 million as of February 27, 2026. Its market cap has decreased by -28.11% in one year.
Market Cap
412.02M
Enterprise Value
265.76M
1-Year Change
-28.11%
Ranking
Category
Stock Price
$2.74
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has decreased from $423.19M to $412.02M, a decrease of -2.64%. That is a compound annual growth rate of -0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 412.02M | -21.49% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 442.95M |
| Verastem | 441.48M |
| DiaMedica Therapeutics | 440.95M |
| PepGen | 428.99M |
| Upstream Bio | 426.90M |
| LENZ Therapeutics | 423.04M |
| Enanta Pharmaceuticals | 418.17M |
| Niagen Bioscience | 414.86M |